Werewolf Therapeutics Financial Overview
Werewolf Therapeutics's market cap is currently $52.42M. The company's EPS TTM is $-0.36; its P/E ratio is -0.66; Werewolf Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
